Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,391,820
  • Shares Outstanding, K 124,288
  • Annual Sales, $ 55,660 K
  • Annual Income, $ -46,450 K
  • 60-Month Beta N/A
  • Price/Sales 60.89
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.23
  • Most Recent Earnings -0.11 on 11/12/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.05 +13.47%
on 10/24/19
31.29 -12.78%
on 10/18/19
+0.16 (+0.59%)
since 10/14/19
3-Month
24.05 +13.47%
on 10/24/19
55.12 -50.49%
on 09/05/19
-16.20 (-37.25%)
since 08/14/19

Most Recent Stories

More News
Adaptive Biotechnologies: 3Q Earnings Snapshot

SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $14 million in its third quarter.

ADPT : 27.29 (+0.07%)
Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results

Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT) today reported financial results for the quarter ended September 30, 2019.

ADPT : 27.29 (+0.07%)
4 Biotech Stocks That Could Keep Beating Wall Street

The biotechnology industry has lagged the broader market so far this year, but these four stocks have done pretty well and should continue to do so.

BMY : 58.51 (-0.48%)
LLY : 111.39 (-1.24%)
ACAD : 45.47 (-2.03%)
CHRS : 18.98 (-1.15%)
CELG : 110.02 (-0.35%)
BIIB : 275.15 (-2.39%)
INCY : 85.79 (-1.88%)
ADPT : 27.29 (+0.07%)
ALEC : 15.51 (-0.96%)
NGM : 14.15 (+9.27%)
TAK : 20.01 (-0.10%)
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019

Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the third quarter of 2019 after market close on Tuesday, November 12, 2019. Company management will host...

ADPT : 27.29 (+0.07%)
Illumina (ILMN) Inks Deal to Commercialize NGS-Based IVD Kits

Illumina (ILMN) aims to expand access to NGS-based IVD test kits and improve patient outcomes through the new partnership deal.

HAE : 119.85 (+0.08%)
QGEN : 37.28 (+5.16%)
ILMN : 298.44 (+0.07%)
ADPT : 27.29 (+0.07%)
Illumina (ILMN) Inks Deal to Develop Distributable Test Kits

Illumina (ILMN) aims to expand access to genomic-based testing and improve patient outcome through the new partnership deal.

CAPR : 1.75 (-1.96%)
GWPH : 106.01 (-4.52%)
ILMN : 298.44 (+0.07%)
ADPT : 27.29 (+0.07%)
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 27.29 (+0.07%)
ILMN : 298.44 (+0.07%)
Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature

Divide & Conquer ("D&C"), a biotechnology company formed in 2018 with a £10 million (approximately $13.1 million) Series A financing from Medicxi. has left stealth mode to mark the publication of another...

NERV : 5.19 (+0.39%)
ADPT : 27.29 (+0.07%)
Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ(R) as Preferred MRD Test for Drug Development Across Amgen's Hematology Franchise

Adaptive Biotechnologies Corporation (Nasdaq:ADPT) today announced it has entered into a global agreement with Amgen for the use of Adaptive's next-generation sequencing (NGS)-based clonoSEQAssay to assess...

AMGN : 218.50 (-0.53%)
ADPT : 27.29 (+0.07%)
Adaptive Biotechnologies: 2Q Earnings Snapshot

SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $15.7 million in its second quarter.

ADPT : 27.29 (+0.07%)
Trade ADPT with:

Business Summary

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage....

See More

Key Turning Points

2nd Resistance Point 28.35
1st Resistance Point 27.82
Last Price 27.29
1st Support Level 26.44
2nd Support Level 25.60

See More

52-Week High 55.12
Fibonacci 61.8% 43.25
Fibonacci 50% 39.59
Fibonacci 38.2% 35.92
Last Price 27.29
52-Week Low 24.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar